KRKA, d.d., Novo mesto (batch control and batch release) / KRKA, d.d., Novo mesto (secondary packaging)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of non-small cell lung cancer (as first-line therapy in the presence of certain mutations, for maintenance therapy, or after ineffective chemotherapy) and for the treatment of metastatic pancreatic cancer in combination with gemcitabine.
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 25 mg ATC: L01EB02
-
The drug is used for the treatment of non-small cell lung cancer (as first-line therapy in the presence of certain mutations, for maintenance therapy, or after ineffective chemotherapy) and for the treatment of metastatic pancreatic cancer in combination with gemcitabine.
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 100 mg ATC: L01EB02
-
The drug is used for the treatment of non-small cell lung cancer (as first-line therapy, for maintenance therapy, or after ineffective chemotherapy) and for the treatment of metastatic pancreatic cancer in combination with gemcitabine.
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 150 mg ATC: L01EB02